Cormedix (CRMD) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CorMedix Inc. announced business updates and the expected launch of DefenCath on January 30, 2024, highlighting that it has received a benefit determination from the Center for Medicare & Medicaid Services. This information was detailed in a press release, which is included with the company’s recent Form 8-K filing.
For further insights into CRMD stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.